Global Clopidogrel in the Chinese market The growth, share, size, trends and forecast report provides in-depth analysis of the China Clopidogrel market including a detailed description about the market size and growth, value, key opportunities on The Clopidogrel market in China and describes the factors which are and will be driving the growth of the industry taking into account the previous growth models with the forecast period 2022
Get a sample PDF of the report –https://www.marketreportsworld.com/enquiry/request-sample/11931831
Clopidogrel is a leading drug in antithrombotic and antiplatelet aggregation. It was approved for sale in the market by the FDA in 1997. The drug was jointly researched and developed by Bristol-Myers Squibb and Sanofi. Before the patent expired in 2012, Plavix was ranked after Lipitor for many years and was the second best-selling drug in the world. After the patent expired, a worldwide wave of biosimilars exploded.
Clopidogrel was developed and marketed very early in China. In 2000, the registration of Clopidogrel from Shenzhen Salubris Pharmaceuticals was first approved under the trade name “Taijia”. In September 2000, Clopidogrel from Sanofi-Aventis and Bristol-Myers Squibb obtained administrative protection in China. In 2001, Sanofi-Aventis’ Clopidogrel was approved for sale in China under the trade name “Plavix”. For years, Clopidogrel has ranked number one in the Chinese antithrombotic drug market, with sales exceeding CNY 2 billion in 2017.
According to the CRI market research, clopidogrel in the Chinese market is dominated by four companies, namely, Sanofi (Hangzhou) Pharmaceutical Co., Ltd. (trade name: Plavix), Shenzhen Salubris Pharmaceutical Co., Ltd. (trade name: Taijia), Lepu Pharmaceutical Co., Ltd. (Trade name: Shuai Tai) and Sanofi (Trade name: Plavix). According to sales in 2017, Sanofi (Hangzhou) achieved a 52% market share, long ranking number one in the Chinese market.
CRI predicts that with an aging population, change in lifestyle and increasing incidence of stroke, myocardial infarction and peripheral arterial thromboembolism, the demand for clopidogrel in the Chinese market will continue to increase. ‘to augment.
History of the development of clopidogrel on the Chinese market
Development environment for clopidogrel in China
Sales of Clopidogrel in China
Main manufacturers of clopidogrel in the Chinese market
Selling price of clopidogrel in the Chinese market
China Clopidogrel Market Outlook, 2018-2022
Inquire Before Purchasing This Report – https://www.marketreportsworld.com/enquiry/pre-order-enquiry/11931831
The China Clopidogrel market report provides an overview of key market drivers, challenges, opportunities and risks and vendor strategies. Key players are also presented with their market share in the global China Clopidogrel market discussed. Overall, this report covers the historical situation, current state and future prospects. Moreover, the global market is segmented on the basis of type, application, offerings, and region. It contains numbers, regions, revenue and offers just like the in-depth calculation of business chain structure, opportunities and industry news analysis. The application part shows the uses of the product.
The China Clopidogrel market report also covers a detailed understanding of the major geographies present in the market along with key segments and sub-segments. The report focuses on the state of regional development, which includes market size, share and volume.
Purchase this report (price 2200 USD for a single user license) – https://www.marketreportsworld.com/purchase/11931831
Detailed Table of Contents of Global Synthesis Gas Market Research Report
1 Relevant concepts of clopidogrel
1.2 History of the development of clopidogrel in China
2 Overview of the clopidogrel market in China
2.1 Patents and government approval for clopidogrel
2.2 Main manufacturers
2.3 Market size
3 China Clopidogrel Sales Survey, 2013-2017
3.1 Sales value
3.1.1 Aggregate Sales Value
3.1.2 Sales value in different regions
3.2 Sales volume
3.2.1 Global Sales Volume
3.2.2 Sales Volume in Different Regions
4 China Clopidogrel Manufacturers Market Share, 2013-2017
4.1 Market share by sales value
4.2 Market share by sales volume
5 Clopidogrel in different dosage forms, 2013-2017
5.1 Clopidogrel Market Share in Different Dosage Forms by Sales Value
5.2 Clopidogrel Market Share in Different Dosage Forms by Sales Volume
6 Benchmark sales price of clopidogrel in the Chinese market, 2017-2018
6.1 Sanofi (Hangzhou) Pharmaceutical Co., Ltd. (Product trade name: Plavix)
6.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. (Product trade name: Taijia)
6.3 Lepu Pharmaceuticals Co., Ltd. (Product trade name: Shuaitai)
6.4 Sanofi (Trade name of the product: Plavix)
Top 7 Manufacturers of Clopidogrel in Chinese Market, 2013-2017
7.1 Sanofi Pharmaceutical Co., Ltd.
7.1.1 Company profile
7.1.2 Sanofi (Hangzhou) Clopidogrel Sales in China
7.2 Shenzhen Salubris Pharmaceuticals Co., Ltd.
7.3 Lepu Pharmaceuticals Co., Ltd.
8 China Clopidogrel Market Outlook, 2018-2022
8.1 Market Size Forecast
8.2 Forecast on development trend
Chart of graphics
Chinese government approval chart for clopidogrel
Chart China Clopidogrel Sales, 2013-2017
Chart China Clopidogrel Sales Value, 2013-2017
Graph of sales value of Clopidogrel in parts of China, 2013-2017
Chart China Clopidogrel Sales Volume, 2013-2017
Chart of Clopidogrel sales volume in parts of China, 2013-2017
Chart Sanofi (Hangzhou) Clopidogrel Sales Value and Market Share, 2013-2017
Chart Shenzhen Salubris Clopidogrel Sales Value and Market Share, 2013-2017
Chart China Clopidogrel Tablets Sales Value and Market Share, 2013-2017
Chart China Clopidogrel Tablets Sales Volume and Market Share, 2013-2017
Chart Sanofi (Hangzhou) Clopidogrel Sale Price in Several Chinese Cities, 2017
Chart Shenzhen Salubris Clopidogrel Sale Price in Several Chinese Cities, 2017
China Clopidogrel Sales Forecast, 2018-2022
Browse the full table of contents at – https://www.marketreportsworld.com/TOC/11931831
About Us: –
World Market Reports is the credible source for getting the market reports that will give you the lead your business needs. The market is changing rapidly with the continued expansion of the industry. The advancement of technology has provided today’s businesses with multifaceted benefits resulting in daily economic changes. Thus, it is very important for a company to understand the patterns of market movements in order to better develop a strategy. An effective strategy gives companies a head start in planning and an advantage over their competitors.
Name: Ajay Plus
E-mail: [email protected]
Call: United States + (1) 424 253 0807 / United Kingdom + (44) 203 239 8187
Other reports here: